SCHEMBL5880322

SCHEMBL5880322

CCC1(CC)C=CC(C(=O)c2cccc(C(=O)c3ccccc3)c2)=CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.47
ATM Q13315 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
PTGS1 P23219 4/20 0.40
PTGS2 P35354 4/20 0.40
MAPT P10636 2/20 0.40
CXCR1 P25024 2/20 0.40
CXCR2 P25025 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.40
ALDH1A1 P00352 2/20 0.40
RECQL P46063 1/20 0.40
KDM4E B2RXH2 1/20 0.40
LMNA P02545 1/20 0.40
CYP3A4 P08684 1/20 0.40
HPGD P15428 1/20 0.40
MAPK1 P28482 1/20 0.40
PMP22 Q01453 1/20 0.40
SLC22A6 Q4U2R8 1/20 0.40
HSD17B10 Q99714 1/20 0.40
CXCL8 P10145 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28425389 0.93 ALDH1A1 (0.42) L3MBTL1ATMTDP1PTGS1PTGS2
SCHEMBL12537746 0.79 ALDH1A1 (0.38) L3MBTL1ATMTDP1MAPTALDH1A1
SCHEMBL27954434 0.78 MAPK1 (0.38) L3MBTL1ATMTDP1SMN1; SMN2ALDH1A1
SCHEMBL10578752 0.77 ALDH1A1 (0.36) L3MBTL1ATMTDP1PTGS1PTGS2
SCHEMBL29088057 0.77 ALDH1A1 (0.36) L3MBTL1ATMTDP1ALDH1A1LMNA
Hexane SCHEMBL27462417 0.76 CES2 (0.41) ALDH1A1HPGD
SCHEMBL136599 0.75 ALDH1A1 (0.43) L3MBTL1ATMTDP1MAPTSMN1; SMN2
SCHEMBL28787232 0.75 ALDH1A1 (0.34) SMN1; SMN2ALDH1A1CYP3A4HPGDGABRA1
SCHEMBL28613712 0.75
Benzophenone SCHEMBL9776685 0.75 ALDH1A1 (0.43) L3MBTL1ATMTDP1SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9969890-B2 Fluorinated ether compound, composition for forming hard coating layer, and article having hard coating layer ASAHI GLASS COMPANY, LIMITED (JP) 2018-05-15 US disclosed
EP-2966110-A1 FLUORINE-CONTAINING ETHER COMPOUND, COMPOSITION FOR FORMING HARD COATING LAYER, AND ARTICLE HAVING HARD COATING LAYER Asahi Glass Company, Limited (JP) 2016-01-13 EP disclosed
US-20150344703-A1 FLUORINATED ETHER COMPOUND, COMPOSITION FOR FORMING HARD COATING LAYER, AND ARTICLE HAVING HARD COATING LAYER ASAHI GLASS COMPANY, LIMITED (JP) 2015-12-03 US disclosed
US-6992140-B2 Curable unsaturated resin composition DAINIPPON INK AND CHEMICALS, INC. (JP) 2006-01-31 US disclosed
US-20040158006-A1 Curable unsaturated resin composition DAINIPPON INK AND CHEMICALS, INC. (JP) 2004-08-12 US disclosed
EP-1400546-A1 CURABLE UNSATURATED RESIN COMPOSITION DAINIPPON INK AND CHEMICALS, INC. (JP) 2004-03-24 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150344703-A1 FLUORINATED ETHER COMPOUND, COMPOSITION FOR FORMING HARD COATING LAYER, AND ARTICLE HAVING HARD COATING LAYER DOT1L, METTL3, METTL14 L3MBTL1 232/4885ATM 2345/4885TDP1 3192/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.